Nouveauté dans la prise en charge thérapeutique de la BPCOROCHE, N; COUILLARD, A.Revue des maladies respiratoires actualités (Print). 2010, Vol 2, Num 6, pp 637-641, issn 1877-1203, 5 p.Article

LE MÉDICAMENT DU MOIS: Indacatérol (Onbrez Breezhaler^®) et broncho-pneumopathie chronique obstructive = INDACATEROL (ONBREZ BREEZHALER^®) AND CHRONIC OBSTRUCTIVE PULMONARY DISEASECORHAY, J.-L; LOUIS, R.RMLG. Revue médicale de Liège. 2011, Vol 66, Num 9, issn 0370-629X, 498-502 [5 p.]Article

Acute effects of indacaterol on lung hyperinflation in moderate COPD: A comparison with tiotropiumROSSI, Andrea; CENTANNI, Stefano; CERVERI, Isa et al.Respiratory medicine. 2012, Vol 106, Num 1, pp 84-90, issn 0954-6111, 7 p.Article

Indacaterol once-daily provides superior efficacy to salmeterol twice-daily in COPD: A 12-week studyKORN, Stephanie; KERWIN, Edward; ATIS, Sibel et al.Respiratory medicine. 2011, Vol 105, Num 5, pp 719-726, issn 0954-6111, 8 p.Article

Profiling the effects of indacaterol on dyspnoea and health status in patients with COPDJONES, Paul W; MAHLER, Donald A; GALE, Rupert et al.Respiratory medicine. 2011, Vol 105, Num 6, pp 892-899, issn 0954-6111, 8 p.Article

Effect of an additional dose of indacaterol in COPD patients under regular treatment with indacaterolCAZZOLA, Mario; SEGRETI, Andrea; STIRPE, Emanuele et al.Respiratory medicine. 2013, Vol 107, Num 1, pp 107-111, issn 0954-6111, 5 p.Article

Blinded 12-week comparison of once-daily indacaterol and tiotropium in COPDBUHL, R; DUNN, L. J; DISDIER, C et al.The European respiratory journal. 2011, Vol 38, Num 4, pp 797-803, issn 0903-1936, 7 p.Article

Effect of indacaterol on exercise endurance and lung hyperinflation in COPDO'DONNELL, Denis E; CASABURI, Richard; VINCKEN, Walter et al.Respiratory medicine. 2011, Vol 105, Num 7, pp 1030-1036, issn 0954-6111, 7 p.Article

Once-daily indacaterol versus twice-daily salmeterol for COPD: a placebo-controlled comparisonKORNMANN, O; DAHL, R; CENTANNI, S et al.The European respiratory journal. 2011, Vol 37, Num 2, pp 273-279, issn 0903-1936, 7 p.Article

A dose-ranging study of indacaterol in obstructive airways disease, with a tiotropium comparisonRENNARD, Stephen; BANTJE, Theo; HIGGINS, Mark et al.Respiratory medicine. 2008, Vol 102, Num 7, pp 1033-1044, issn 0954-6111, 12 p.Article

Indacaterol: In Chronic Obstructive Pulmonary DiseaseMOEN, Marit D.Drugs (Basel). 2010, Vol 70, Num 17, pp 2269-2280, issn 0012-6667, 12 p.Article

Assessing efficacy of indacaterol in moderate and severe COPD patients: A 12-week study in an Asian populationTO, Yasuo; KINOSHITA, Masaharu; KRAMER, Benjamin et al.Respiratory medicine. 2012, Vol 106, Num 12, pp 1715-1721, issn 0954-6111, 7 p.Article

Indacaterol therapy in patients with COPD not receiving other maintenance treatmentDECRAMER, Marc; ROSSI, Andrea; LAWRENCE, David et al.Respiratory medicine. 2012, Vol 106, Num 12, pp 1706-1714, issn 0954-6111, 9 p.Article

24-h bronchodilator efficacy of single doses of indacaterol in Japanese patients with asthma: A comparison with placebo and salmeterolSUGIHARA, Naruhiko; KANADA, Shigeto; HAIDA, Michiko et al.Respiratory medicine. 2010, Vol 104, Num 11, pp 1629-1637, issn 0954-6111, 9 p.Article

Indacaterol provides sustained 24 h bronchodilation on once-daily dosing in asthma : a 7-day dose-ranging study : AsthmaLAFORCE, C; ALEXANDER, M; DECKELMANN, R et al.Allergy (Copenhagen). 2008, Vol 63, Num 1, pp 103-111, issn 0105-4538, 9 p.Article

Combined long-acting bronchodilator single therapy for COPDRAJNOVEANU, Ruxandra Mioara; ANTONIU, Sabina; ULMEANU, Ruxandra et al.Expert opinion on pharmacotherapy. 2014, Vol 15, Num 1, pp 139-142, issn 1465-6566, 4 p.Article

Effects of long-acting bronchodilators in COPD patients according to COPD severity and ICS useDECRAMER, Marc; DAHL, Ronald; KORNMANN, Oliver et al.Respiratory medicine. 2013, Vol 107, Num 2, pp 223-232, issn 0954-6111, 10 p.Article

Indacaterol once-daily is equally effective dosed in the evening or morning in COPDMAGNUSSEN, H; VERKINDRE, C; JACK, D et al.Respiratory medicine. 2010, Vol 104, Num 12, pp 1869-1876, issn 0954-6111, 8 p.Article

Indacaterol, a novel inhaled β₂-agonist, provides sustained 24-h bronchodilation in asthmaBEEH, K. M; DEROM, E; KANNIESS, F et al.The European respiratory journal. 2007, Vol 29, Num 5, pp 871-878, issn 0903-1936, 8 p.Article

Safety and tolerability of indacaterol in asthma : A randomized, placebo-controlled 28-day studyCHUCHALIN, Alexander G; TSOI, Alla N; VAN AS, Andre et al.Respiratory medicine. 2007, Vol 101, Num 10, pp 2065-2075, issn 0954-6111, 11 p.Article

Cardio- and cerebrovascular safety of indacaterol vs formoterol, salmeterol, tiotropium and placebo in COPDWORTH, Heinrich; KIAN FAN CHUNG; FELSER, James M et al.Respiratory medicine. 2011, Vol 105, Num 4, pp 571-579, issn 0954-6111, 9 p.Article

Indacaterol: A Novel Long-Acting β₂-AgonistRAY, Shaunta' M; MCMILLEN, James C; TREADWAY, Sarah A et al.Pharmacotherapy. 2012, Vol 32, Num 5, pp 456-474, issn 0277-0008, 19 p.Article

Efficacy and Tolerability of Indacaterol 75 μg Once Daily in Patients Aged ≥40 Years With Chronic Obstructive Pulmonary Disease: Results From 2 Double-Blind, Placebo-Controlled 12-Week StudiesKERWIN, Edward M; GOTFRIED, Mark H; LAWRENCE, David et al.Clinical therapeutics. 2011, Vol 33, Num 12, pp 1974-1984, issn 0149-2918, 11 p.Article

Novel long-acting bronchodilators for COPD and asthmaCAZZOLA, M; MATERA, M. G.British journal of pharmacology. 2008, Vol 155, Num 3, pp 291-299, issn 0007-1188, 9 p.Article

Pharmacogenetic characterization of indacaterol, a novel β₂-adrenoceptor agonistSAYERS, I; HAWLEY, J; STEWART, C. E et al.British journal of pharmacology. 2009, Vol 158, Num 1, pp 277-286, issn 0007-1188, 10 p.Article